At this Year’s ASH, ‘Multiple Important Data Presentations’

When the abstracts for the upcoming annual meeting of the American Society for Hematology were released last week, results of Geron Corp.’s Imetelstat were the biggest attention-grabber as far as the market was concerned. (See BioWorld Today, Nov. 8, 2013.)